A multivariate analysis on prognostic factors for lobular carcinoma of the breast
Keywords:
Carcinoma, lobular, Prognosis, Lymph node excision, Drug therapy, RadiotherapyAbstract
CONTEXT AND OBJECTIVE: Lobular carcinoma is the second most common type of breast neoplasia and has unique clinical and pathological features. Our aim was to evaluate prognostic factors for this type of breast cancer. DESIGN AND SETTING: Retrospective study at a tertiary oncological institution. METHODS: 162 patients diagnosed and treated between January 1985 and January 2002 were included. The inclusion criteria were: absence of previous treatment, histological diagnosis of lobular carcinoma, no previous history of breast cancer and minimum follow-up of 36 months. RESULTS: In univariate analysis, the following factors were statistically significant: clinical stage T (P = 0.0005), clinical stage N (P = 0.0014), neoadjuvant chemotherapy (P = 0.0008), primary tumor size (P < 0.0001), vascular invasion (P < 0.0001), lymphatic invasion (P = 0.0004), neural invasion (P = 0.0004), skin invasion (P < 0.0001), capsular transposition (P = 0.0008), lymph node ratio (P < 0.0001), estrogen receptor expression (P = 0.0186), progesterone receptor expression (P = 0.0286), pathological stage T (P < 0.0001), pathological stage N (P < 0.0001), adjuvant chemotherapy (P < 0.0001) and postoperative hormone therapy (P = 0.0367). After grouping the variables, multivariate analysis was performed. Presence of lymph node metastases, capsular transposition, lymph node ratio and postoperative hormone therapy remained significant. CONCLUSION: In this series, the most important prognostic factors for lobular carcinoma of the breast seemed to relate to lymph node status and presence of capsular transposition. Factors relating to axillary involvement, capsular transposition and hormone therapy were significant for survival.
Downloads
References
Berg JW, Hutter RV. Breast cancer. Cancer. 1995;75(1 Suppl):257-69.
Li CI, Anderson BO, Daling JR, Moe RE. Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA. 2003;289(11):1421-4.
Fisher ER, Gregorio RM, Fisher B, et al. The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4). Cancer. 1975;36(1):1-85.
Martinez V, Azzopardi JG. Invasive lobular carcinoma of the breast: incidence and variants. Histopathology. 1979;3(6):467-88.
Arpino G, Bardou VJ, Clark GM, Elledge RM. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res. 2004;6(3):R149-56.
Ferlicot S, Vincent-Salomon A, Médioni J, et al. Wide metastatic spreading in infiltrating lobular carcinoma of the breast. Eur J Cancer. 2004;40(3):336-41.
Cocquyt VF, Schelfhout VR, Blondeel PN, et al. The role of biological markers as predic- tors of response to preoperative chemotherapy in large primary breast cancer. Med Oncol. 2003;20(3):221-31.
Greene FL, Compton CC, Fritz AG, Shah J, Winchester DP. AJCC Cancer staging atlas. New York: Springer; 2002.
Kleinbaum DG, Kupper LL, Muller KE, Nizam A. Applied regression analysis and multivariate methods. Pacific Grove: Books/Cole; 1998.
Moreno-Elola A, Aguilar A, Roman JM, et al. Prognostic factors in invasive lobular carcinoma of the breast: a multivariate analysis. A multicentre study after seventeen years of follow-up. Ann Chir Gynaecol. 1999;88(4):252-8.
Ladekarl M, Sørensen FB. Prognostic, quantitative histopathologic variables in lobular carci- noma of the breast. Cancer. 1993;72(9):2602-11.
Talman ML, Jensen MB, Rank F. Invasive lobular breast cancer. Prognostic significance of histological malignancy grading. Acta Oncol. 2007;46(6):803-9.
Rakha EA, El-Sayed ME, Menon S, Green AR, Lee AH, Ellis IO. Histologic grading is an inde- pendent prognostic factor in invasive lobular carcinoma of the breast. Breast Cancer Res Treat. 2008;111(1):121-7.
Dixon JM, Anderson TJ, Page DL, Lee D, Duffy SW, Stewart HJ. Infiltrating lobular carcinoma of the breast: an evaluation of the incidence and consequence of bilateral disease. Br J Surg. 1983;70(9):513-6.
Toikkanen S, Pylkkänen L, Joensuu H. Invasive lobular carcinoma of the breast has better short- and long-term survival than invasive ductal carcinoma. Br J Cancer. 1997;76(9): 1234-40.
Jayasinghe UW, Bilous AM, Boyages J. Is survival from infiltrating lobular carcinoma of the beast different from that of infiltrating ductal carcinoma? Breast J. 2007;13(5):479-85.
van der Wal BC, Butzelaar RM, van der Meij S, Boermeester MA. Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in stage I and II breast cancer. Eur J Surg Oncol. 2002;28(5):481-9.
